「de」の検索結果
168件：66～70件目を表示
-
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
規TRPV1拮抗薬モツギバトレプのドライアイ患者を対象とした第Ⅲ相比較試験 堀 裕一、和田智之、尾松和則 もっと見る 海外 ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatr...
https://www.senju.co.jp/rd/society/ -
Quality Policies | About Senju | SENJU Pharmaceutical
ory agencies. Quality Policies We always pay close attention to the quality of our products to provide customers with better pharmaceuticals and comply with laws and standards with high ethical standa...
http://www.senju.co.jp/english/about/quality.html -
お知らせ | 千寿製薬株式会社
almic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic sus...
http://www.senju.co.jp/english/news/ -
NewMytear CL Cool-s | OTC Products, etc. | Products | SENJU Pharmaceutical
oft). Can be used by persons who do not wear contact lenses. An eye drop containing potassium chloride and sodium chloride (which are minerals contained in tears), taurine (which helps to repair the c...
http://www.senju.co.jp/english/products/clcool-s.html -
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
http://www.senju.co.jp/english/about/message.html